AIDS Treatment News Issue #349, August 18, 2000
John S. James
Comment: We usually find the HIV/AIDS presentations less important in even-numbered years, when ICAAC competes with the International AIDS Conference. But this year a number of researchers did not go to Durban, South Africa, for the international meeting, so this ICAAC may be more important than most which occur on International AIDS Conference years. And researchers who did present in Durban are more likely to speak in Toronto as well, as much of the audience there did not get to Durban.
The abstracts for the ICAAC conference (except for late breakers) will be online later this month, and can be found through the main ICAAC conference page, http://www.asmusa.org/mtgsrc/40icaac.htm
Meanwhile, a preliminary list of oral presentations is already online; we selected the following, which may be of interest to our readers:
* Update in Infectious Diseases. Conveners Ferric C. Fang, Robert T. Schooley, and David A. Relman. An overview of last year's most noteworthy papers on infectious diseases.
* Keynote Session: HIV / AIDS: From Discovery, to Prevention and Therapy. Conveners David A. Cooper, Michael S. Saag, and H. Clifford Lane:
AIDS as a Zoonosis: Scientific and Public Health Implications, Beatrice H. Hahn
Progress in HIV Vaccine Development, Gary J Nabel Antiretroviral Therapy--A Limited Success Story
* in Emerging Infections section:
Emerging MRSA in the Community, Julie L. Gerberding, CDC, Atlanta
The Growing Challenge of Fresh Produce-associated Foodbourne Infections, Cindy R. Friedman
Amebiasis: It Was Always There and We Didn't Know It, William A. Petri
* in DNA Sequencing as a Diagnostic Tool: Getting to First Base:
Using DNA Sequencing to Monitor Resistance in HIV, Robert W. Shafer
* in Innate Immunity: Antimicrobial Peptides, Tomas Ganz
Lipodystrophy and Metabolic Complications of HIV, Conveners
David A. Cooper, Michael S. Saag, and H. Clifford Lane: Mitochondrial Toxicity: Mechanism and Spectrum, William Lewis Mechanism and Treatment for Insulin Resistance in HIV Lipodystrophy, Steven K. Grinspoon Cardiovascular Epidemiology in the Context of HIV Disease, Matthias Egger The Strategy of Antiretroviral Switch Studies -- A Review, William G. Powderly
* T-cell Responses to Viruses. Conveners Paul D. Griffiths and Louis J. Picker: Laboratory Techniques, L.K. Borysiewicz HIV and CMV, Louis J. Picker Epstein-Barr Virus and Adoptive T-Cell Therapy, Cliona Rooney HCV, Rodney E. Phillips.
* Tuberculosis: Problems and Promises. Conveners Renee Ridzon and Jerrold J. Ellner: New Insights into the Transmission of TB, Renee Ridzon How Molecular Approaches Contribute to Our Understanding of TB, Barry N. Kreiswirth Understanding the Pathogenesis of Tuberculosis and the Implications for Immunotherapy, Gilla Kaplan Microbiological Monitoring of Tuberculosis for Therapeutic Endpoints, Robert S. Wallis Is Tuberculosis a Vaccine-preventable Illness? What's on the Horizon? William Jacobs
* Viral Co-infections with HIV, conveners TBA: HHV-8 and HIV, Lawrence Corey Hepatitis C, David Thomas CMV, Michael Polis
* Current Issues in the Management of HIV-infected Patients. Conveners Paul A. Volberding and Constance A. Benson The Clinical Use of Resistance Testing, Douglas D. Richman Management of Metabolic Complications of Therapy, Judith S. Currier The Dilemma of Treatment Interruption, Roy M. Gulick
* Also, several of the Meet-the-Experts Roundtables are relevant: Antiretroviral Therapy I, with Christine Katlama and Robert L. Murphy. Antiretroviral Therapy II, with William Cameron and Calvin Cohen. Antiretroviral Therapy III, with Roy M. Gulick and Michael S. Saag. Infection Control in Multidrug-resistant Pathogens [antibiotic resistance, not antiretroviral], with Robert A. Weinstein and John M. Conly. Stopping Opportunistic Infection Prophylaxis, with Henry Masur and Wafaa El-Sadr. What to Do When the Condom Breaks, with James Kahn and Julie L. Gerberding.
Registration, Housing, Other Information
Registration and other information is available through the ICAAC Web site, http://www.asmusa.org/mtgsrc/40icaac.htm This conference is relatively inexpensive; general onsite registration is $350.
000818
ATN34905
Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .